Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selumetinib and docetaxel in advanced gastric adenocarcinoma
NCT02448290Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Nov 2014
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selumetinib in gastric adenocarcinoma, sponsored by Samsung Medical Center. Started Nov 2014; status: completed.
02
Drugs
selumetinib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT02448290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448290.